Filed under: Stocks to Buy
Becton Dickinson (BDX), first discussed here on March 17, 2009 at a price of $65.66, remains well-positioned for the new U.S. health care era.Look for Becton's 2010 revenue to surge 8-11% a a result of strong gains in its medical segment; diagnostics revenue should also rise substantially as demand for safety products and infectious disease/flu-related products sees steadily increasing global demand. Meanwhile, the bioservices unit revenue will likely trail the above, but still record 3-5% growth in 2010.
Continue reading Becton Is Ready for the New U.S. Health Care Era
Becton Is Ready for the New U.S. Health Care Era originally appeared on BloggingStocks on Thu, 25 Mar 2010 18:00:00 EST. Please see our terms for use of feeds.
Permalink | Email this | CommentsFull story at http://www.pheedcontent.com/click.phdo?i=c873838e5c015cdc110a02c819405fc8
No comments:
Post a Comment